Your browser doesn't support javascript.
loading
The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study.
Rubin-Kahana, Dafna Sara; Shelef, Assaf; Weizman, Abraham; Gothelf, Doron; Timinski, Igor; Spivak, Baruch; Stryjer, Rafael.
Affiliation
  • Rubin-Kahana DS; Beer-Yaacov - Ness-Ziona Mental Health Center.
  • Shelef A; Abarbanel Mental Health Center, Bat-Yam.
  • Weizman A; Felsenstein Medical Research Center, Petah Tikva.
  • Gothelf D; The Child Psychiatry Division, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer.
  • Timinski I; Sagol School of Neuroscience, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Spivak B; Beer-Yaacov - Ness-Ziona Mental Health Center.
  • Stryjer R; Beer-Yaacov - Ness-Ziona Mental Health Center.
Int Clin Psychopharmacol ; 34(4): 179-183, 2019 07.
Article in En | MEDLINE | ID: mdl-31058717

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Citalopram / Obsessive-Compulsive Disorder Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Citalopram / Obsessive-Compulsive Disorder Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United kingdom